On univariate competing risk analysis, the factors significantly associated with risk of IBTR were young age at diagnosis (≦49), presentation (clinical), positive margin status by the polygon method, large size of DCIS (≧21 mm) and 3+ HER2 status. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.